Subscribe to RSS
DOI: 10.1055/s-0037-1603942
Fetomaternal and Pediatric Toxoplasmosis
Publication History
12 January 2017
12 April 2017
Publication Date:
19 June 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00029028/201704/lookinside/thumbnails/10-1055-s-0037-1603942_1700025-1.jpg)
Abstract
Toxoplasmosis is one of the most important causes of foodborne illnesses and inflammatory complications, as well as congenital disorders. Promiscuous Toxoplasma is transmitted by contaminated food and animal produce, water, vegetations, fruits, and sexually through semen. Toxoplasma infects nucleated cells with a unique tropism for muscles and central nervous system and a mind bugging malicious effect. Pregnant women with acute or reactivated toxoplasmosis can transmit Toxoplasma via transplacental transmission to the fetus. The severity of congenital toxoplasmosis depends on the gestation period, as infection in early pregnancy causes more severe consequences. Congenital toxoplasmosis complications include miscarriage, encephalitis, neurological retardation, mental illnesses, auditory, and visual inflammatory disorders, cardiovascular abnormalities, and pains. Current therapies are inefficient for congenital and chronic toxoplasmosis or have severe side effects with life-threatening complications. There is an urgent need for effective and safe therapeutic modalities to treat complications of toxoplasmosis and effective vaccines to eliminate the infectious agent. This investigation will discuss the pathogenesis of fetomaternal, congenital, and pediatric toxoplasmosis, the currently available therapies in practice, and explore those therapeutic modalities in experimental stages for promising future trials.
-
References
- 1 Hoffmann S, Batz MB, Morris Jr JG. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J Food Prot 2012; 75 (07) 1292-1302
- 2 Oz HS. Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon. Front Microbiol 2014; 5: 385 . doi: 10.3389/fmicb.2014.00385
- 3 Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol 2008; 38 (11) 1257-1278
- 4 Elsheikha HM, Büsselberg D, Zhu XQ. The known and missing links between Toxoplasma gondii and schizophrenia. Metab Brain Dis 2016; 31 (04) 749-759
- 5 Bierly AL, Shufesky WJ, Sukhumavasi W, Morelli AE, Denkers EY. Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J Immunol 2008; 181 (12) 8485-8491
- 6 Scallan E, Griffin PM, Angulo FJ, Tauxe RV, Hoekstra RM. Foodborne illness acquired in the United States--unspecified agents. Emerg Infect Dis 2011; 17 (01) 16-22
- 7 Hotez PJ. Neglected infections of poverty in the United States of America. PLoS Negl Trop Dis 2008; 2 (06) e256
- 8 Wolf A, Cowen D, Paige B. Human toxoplasmosis: occurrence in infants as an encephalomyelitis verification by transmission to animals. Science 1939; 89 (2306): 226-227
- 9 Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R. Congenital toxoplasmosis: a review. Obstet Gynecol Surv 2001; 56 (05) 296-305
- 10 Dehkordi FS, Borujeni MR, Rahimi E, Abdizadeh R. Detection of Toxoplasma gondii in raw caprine, ovine, buffalo, bovine, and camel milk using cell cultivation, cat bioassay, capture ELISA, and PCR methods in Iran. Foodborne Pathog Dis 2013; 10 (02) 120-125
- 11 Sharif M, Sarvi Sh, Shokri A. , et al. Toxoplasma gondii infection among sheep and goats in Iran: a systematic review and meta-analysis. Parasitol Res 2015; 114 (01) 1-16
- 12 Oz HS. Fetal and maternal toxoplasmosis. In: Lee CM. , ed. Recent Advances in Toxoplasmosis Research. Lexington, KY: Nova Science Publications; 2014: 1-34
- 13 Muzzio DO, Soldati R, Rolle L, Zygmunt M, Zenclussen AC, Jensen F. B-1a B cells regulate T cell differentiation associated with pregnancy disturbances. Front Immunol 2014; 5: 6 . doi: 10.3389/fimmu.2014.00006
- 14 Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med 2001; 345 (19) 1400-1408
- 15 Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 2012; 139 (11) 1375-1424
- 16 Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353 (9167): 1829-1833
- 17 Remington JS, McLeod R, Wilson CB, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado YA. , eds. Infectious Diseases of the Fetus and Newborn Infant. 7th Edition. Philadelphia, PA: Elsevier Saunders; 2011: 915-1041
- 18 Gilbert R, Gras L. ; European Multicentre Study on Congenital Toxoplasmosis. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003; 110 (02) 112-120
- 19 Gras L, Wallon M, Pollak A. , et al; European Multicenter Study on Congenital Toxoplasmosis. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr 2005; 94 (12) 1721-1731
- 20 McLeod R, Boyer K, Karrison T. , et al; Toxoplasmosis Study Group. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis 2006; 42 (10) 1383-1394
- 21 Boyer K, Hill D, Mui E. , et al; Toxoplasmosis Study Group. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin Infect Dis 2011; 53 (11) 1081-1089
- 22 Mead PS, Slutsker L, Dietz V. , et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5 (05) 607-625
- 23 Carral L, Kaufer F, Olejnik P, Freuler C, Durlach R. Prevention of congenital toxoplasmosis in a Buenos Aires hospital [in Spanish]. Medicina (B Aires) 2013; 73 (03) 238-242
- 24 Buxton D, Thomson K, Maley S, Wright S, Bos HJ. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet Rec 1991; 129 (05) 89-93
- 25 Oz HS, Tobin T. Atovaquone ameliorate gastrointestinal toxoplasmosis complications in a pregnancy model. Med Sci Monit 2012; 18 (09) BR337-BR345
- 26 House PK, Vyas A, Sapolsky R. Predator cat odors activate sexual arousal pathways in brains of Toxoplasma gondii infected rats. PLoS One 2011; 6 (08) e23277 . doi: 10.1371/journal.pone.0023277
- 27 Knight K. How pernicious parasites turn victims into zombies. J Exp Biol 2013; 216 (Pt 1): i-iv
- 28 Wanderley FS, Porto WJ, Câmara DR. , et al. Experimental vaginal infection of goats with semen contaminated with the “CPG” strain of Toxoplasma gondii. J Parasitol 2013; 99 (04) 610-613
- 29 Arantes TP, Lopes WD, Ferreira RM. , et al. Toxoplasma gondii: Evidence for the transmission by semen in dogs. Exp Parasitol 2009; 123 (02) 190-194
- 30 Lopes WD, Rodriguez JD, Souza FA. , et al. Sexual transmission of Toxoplasma gondii in sheep. Vet Parasitol 2013; 195 (1-2): 47-56
- 31 Brown AS, Schaefer CA, Quesenberry Jr CP, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005; 162 (04) 767-773
- 32 Bachmann S, Schröder J, Bottmer C, Torrey EF, Yolken RH. Psychopathology in first-episode schizophrenia and antibodies to Toxoplasma gondii. Psychopathology 2005; 38 (02) 87-90
- 33 Wang HL, Wang GH, Li QY, Shu C, Jiang MS, Guo Y. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand 2006; 114 (01) 40-48
- 34 Flegr J. Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J Exp Biol 2013; 216 (Pt 1): 127-133
- 35 Fekadu A, Shibre T, Cleare AJ. Toxoplasmosis as a cause for behaviour disorders--overview of evidence and mechanisms. Folia Parasitol (Praha) 2010; 57 (02) 105-113
- 36 Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 2007; 33 (03) 729-736
- 37 Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psychiatry 2012; 69 (11) 1123-1130
- 38 Zhang Y, Träskman-Bendz L, Janelidze S. , et al. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J Clin Psychiatry 2012; 73 (08) 1069-1076
- 39 Kaňková S, Sulc J, Křivohlavá R, Kuběna A, Flegr J. Slower postnatal motor development in infants of mothers with latent toxoplasmosis during the first 18 months of life. Early Hum Dev 2012; 88 (11) 879-884
- 40 Gale SD, Berrett AN, Brown B, Erickson LD, Hedges DW. No association between current depression and latent toxoplasmosis in adults. Folia Parasitol (Praha) 2016; 63: 32
- 41 Shapira Y, Agmon-Levin N, Selmi C. , et al. Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases. J Autoimmun 2012; 39 (1-2): 112-116
- 42 Oz HS. Toxoplasmosis, Pancreatitis, Obesity and Drug Discovery. Pancreat Disord Ther 2014; 4 (02) 1-3 . doi: http://dx.doi.org/10.4172/2165-7092.1000138. Accessed June 8, 2017
- 43 Oz HS, Chen T, de Villiers WJ. Green tea polyphenols and sulfasalazine have parallel anti-inflammatory properties in colitis models. Front Immunol 2013; 4 (132) 132 . doi: 10.3389/fimmu.2013.00132
- 44 Oz HS, Chen T, Ebersole JL. A model for chronic mucosal inflammation in IBD and periodontitis. Dig Dis Sci 2010; 55 (08) 2194-2202
- 45 Brandtzaeg P. Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses?. Acta Odontol Scand 2001; 59 (04) 235-243
- 46 Epple HJ. Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease. Dig Dis 2009; 27 (04) 555-559
- 47 Oz HS. Toxoplasmosis complications and novel therapeutic synergism combination of diclazuril plus atovaquone. Front Microbiol 2014; 5: 484
- 48 Oz HS, Tobin T. Diclazuril protects against maternal gastrointestinal syndrome and congenital toxoplasmosis. Int J Clin Med 2014; 5 (03) 93-101
- 49 Erridge C, Duncan SH, Bereswill S, Heimesaat MM. The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. PLoS One 2010; 5 (02) e9125 . doi: 10.1371/journal.pone.0009125
- 50 Lidar M, Langevitz P, Barzilai O. , et al. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann N Y Acad Sci 2009; 1173: 640-648
- 51 Portugal LR, Fernandes LR, Alvarez-Leite JI. Host cholesterol and inflammation as common key regulators of toxoplasmosis and artherosclerosis development. Expert Rev Anti Infect Ther 2009; 7 (07) 807-819
- 52 Lige B, Sampels V, Coppens I. Characterization of a second sterol-esterifying enzyme in Toxoplasma highlights the importance of cholesterol storage pathways for the parasite. Mol Microbiol 2013; 87 (05) 951-967
- 53 Carter CJ. Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders. J Pathog 2013; 2013: 1-29 http://dx.doi.org/10.1155/2013/965046
- 54 Montoya JG, Remington JS. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis 1996; 23 (02) 277-282
- 55 Petersen E, Schmidt DR. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?. Expert Rev Anti Infect Ther 2003; 1 (01) 175-182
- 56 Armstrong L, Isaacs D, Evans N. Severe neonatal toxoplasmosis after third trimester maternal infection. Pediatr Infect Dis J 2004; 23 (10) 968-969
- 57 Teixeira LE, Kanunfre KA, Shimokawa PT. , et al. The performance of four molecular methods for the laboratory diagnosis of congenital toxoplasmosis in amniotic fluid samples. Rev Soc Bras Med Trop 2013; 46 (05) 584-588
- 58 Dando C, Gabriel KE, Remington JS, Parmley SF. Simple and efficient method for measuring anti-toxoplasma immunoglobulin antibodies in human sera using complement-mediated lysis of transgenic tachyzoites expressing beta-galactosidase. J Clin Microbiol 2001; 39 (06) 2122-2125
- 59 Mizejewski GJ. Physiology of alpha-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome. Exp Biol Med (Maywood) 2007; 232 (08) 993-1004
- 60 Kaur M, Verma IC. Serum alpha feto-protein screening in high risk pregnancies. Indian J Pediatr 1995; 62 (01) 101-107
- 61 Olariu TR, Remington JS, Montoya JG. Polymerase chain reaction in cerebrospinal fluid for the diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J 2014; 33 (06) 566-570
- 62 di Carlo P, Romano A, Casuccio A. , et al. Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: a prospective study. Acta Pharmacol Sin 2011; 32 (08) 1063-1070
- 63 Centers for Disease Control and Prevention. Parasites -toxoplasmosis (Toxoplasma infection). Available at: https://www.cdc.gov/parasites/toxoplasmosis/ . Accessed March 2017
- 64 Avelino MM, Amaral WN, Rodrigues IM. , et al. Congenital toxoplasmosis and prenatal care state programs. BMC Infect Dis 2014; 14: 33
- 65 Habib FA. Post-treatment assessment of acute Toxoplasma infection during pregnancy. J Obstet Gynaecol 2008; 28 (06) 593-595
- 66 Bessières MH, Berrebi A, Cassaing S. , et al. Diagnosis of congenital toxoplasmosis: prenatal and neonatal evaluation of methods used in Toulouse University Hospital and incidence of congenital toxoplasmosis. Mem Inst Oswaldo Cruz 2009; 104 (02) 389-392
- 67 Hudson AT, Dickins M, Ginger CD. , et al. 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exp Clin Res 1991; 17 (09) 427-435
- 68 Dunay IR, Heimesaat MM, Bushrab FN. , et al. Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Antimicrob Agents Chemother 2004; 48 (12) 4848-4854
- 69 Cortina-Borja M, Tan HK, Wallon M. , et al; European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med 2010; 7 (10) e1000351 . doi: 10.1371/journal.pmed.1000351
- 70 Hughes WT, Oz HS. Successful prevention and treatment of babesiosis with atovaquone. J Infect Dis 1995; 172 (04) 1042-1046
- 71 Oz HS, Westlund KH. “Human babesiosis”: an emerging transfusion dilemma. Int J Hepatol 2012; 2012: 1-5 . doi: 10.1155/2012/431761
- 72 Freyre A, Falcón J, Méndez J, González M. Toxoplasma gondii: an improved rat model of congenital infection. Exp Parasitol 2008; 120 (02) 142-146
- 73 Srivastava IK, Vaidya AB. A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob Agents Chemother 1999; 43 (06) 1334-1339
- 74 Rolan PE, Mercer AJ, Tate E, Benjamin I, Posner J. Disposition of atovaquone in humans. Antimicrob Agents Chemother 1997; 41 (06) 1319-1321
- 75 Köhler S, Delwiche CF, Denny PW. , et al. A plastid of probable green algal origin in Apicomplexan parasites. Science 1997; 275 (5305): 1485-1489
- 76 Hackstein JH, Mackenstedt U, Mehlhorn H, Meijerink JP, Schubert H, Leunissen JA. Parasitic apicomplexans harbor a chlorophyll a-D1 complex, the potential target for therapeutic triazines. Parasitol Res 1995; 81 (03) 207-216
- 77 Zhou W, Quan JH, Lee YH, Shin DW, Cha GH. Toxoplasma gondii Proliferation Require Down-Regulation of Host Nox4 Expression via Activation of PI3 Kinase/Akt Signaling Pathway. PLoS One 2013; 8 (06) e66306
- 78 Oz HS. Novel synergistic protective efficacy of atovaquone and diclazuril on fetal-maternal toxoplasmosis. Int J Clin Med 2014; 5 (15) 921-932
- 79 Assis RC, Luns FD, Beletti ME. , et al. Histomorphometry and macroscopic intestinal lesions in broilers infected with Eimeria acervulina. Vet Parasitol 2010; 168 (3-4): 185-189